$IRBT
IROBOT CORP Stock $irbt

$irbt Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000115916723000036 Filed on May 09, 2023

Income Statement

Concept	2023 Q2
Revenue	$160.3M
YoY Change	-45.1%
Cost Of Revenue	$123.7M
YoY Change	-32.91%
Gross Profit	$36.55M
YoY Change	-66.0%
Gross Profit Margin	22.8%
Selling, General & Admin	$75.74M
YoY Change	-13.7%
% of Gross Profit	207.21%
Research & Development	$41.93M
YoY Change	-1.4%
% of Gross Profit	114.73%
Depreciation & Amortization	$7.542M
YoY Change	-32.91%
% of Gross Profit	20.63%
Operating Expenses	$117.8M
YoY Change	-9.9%
Operating Profit	-$81.30M
YoY Change	249.12%
Interest Expense	$0.00
YoY Change	-100.0%
% of Operating Profit
Other Income/Expense, Net	-$1.077M
YoY Change	-93.57%
Pretax Income	-$82.37M
YoY Change	105.77%
Income Tax	-$1.300M
% Of Pretax Income
Net Earnings	-$81.11M
YoY Change	166.76%
Net Earnings / Revenue	-50.6%
Basic Earnings Per Share	-$2.95
Diluted Earnings Per Share	-$2.95
COMMON SHARES
Basic Shares Outstanding	27.47M shares
Diluted Shares Outstanding	27.47M shares

Balance Sheet

Concept	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.92M
YoY Change	-57.78%
Cash & Equivalents	$47.90M
Short-Term Investments
Other Short-Term Assets	$56.99M
YoY Change	-41.1%
Inventory	$229.7M
Prepaid Expenses
Receivables	$29.65M
Other Receivables	$0.00
Total Short-Term Assets	$364.2M
YoY Change	-43.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$55.77M
YoY Change	-22.4%
Goodwill	$169.6M
YoY Change	-0.23%
Intangibles	$10.92M
YoY Change	-58.99%
Long-Term Investments	$15.10M
YoY Change	-1.31%
Other Assets	$23.46M
YoY Change	-39.59%
Total Long-Term Assets	$300.4M
YoY Change	-22.89%
TOTAL ASSETS
Total Short-Term Assets	$364.2M
Total Long-Term Assets	$300.4M
Total Assets	$664.6M
YoY Change	-35.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$74.01M
YoY Change	-57.19%
Accrued Expenses	$100.9M
YoY Change	12.89%
Deferred Revenue
YoY Change
Short-Term Debt	$27.00M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$214.0M
YoY Change	-22.35%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$23.08M
YoY Change	-9.78%
Total Long-Term Liabilities	$55.19M
YoY Change	-15.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$214.0M
Total Long-Term Liabilities	$55.19M
Total Liabilities	$269.2M
YoY Change	-21.12%
SHAREHOLDERS EQUITY
Retained Earnings	$118.3M
YoY Change	-74.02%
Common Stock	$264.1M
YoY Change	15.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$395.4M
YoY Change
Total Liabilities & Shareholders Equity	$664.6M
YoY Change	-35.88%

Cashflow Statement

Concept	2023 Q2
OPERATING ACTIVITIES
Net Income	-$81.11M
YoY Change	166.76%
Depreciation, Depletion And Amortization	$7.542M
YoY Change	-32.91%
Cash From Operating Activities	-$94.50M
YoY Change	-7.64%
INVESTING ACTIVITIES
Capital Expenditures	$1.456M
YoY Change	-53.23%
Acquisitions
YoY Change
Other Investing Activities	$73.00K
YoY Change	-85.4%
Cash From Investing Activities	-$1.529M
YoY Change	-112.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$0.00
YoY Change
Cash From Financing Activities	$25.41M
YoY Change	-3595.05%
NET CHANGE
Cash From Operating Activities	-$94.50M
Cash From Investing Activities	-$1.529M
Cash From Financing Activities	$25.41M
Net Change In Cash	-$70.03M
YoY Change	-21.68%
FREE CASH FLOW
Cash From Operating Activities	-$94.50M
Capital Expenditures	$1.456M
Free Cash Flow	-$95.96M
YoY Change	-8.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001159167
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-04-01
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	001-36414
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	iROBOT CORPORATION
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0259335
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	8 Crosby Drive
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Bedford
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01730
CY2023Q2	dei	City Area Code CityAreaCode	781
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	430-3000
CY2023Q2	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2023Q2	dei	Trading Symbol TradingSymbol	IRBT
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27594072	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47915000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117949000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29645000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	66025000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	229688000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	285250000	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	56987000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	59076000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	364235000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	528300000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	55774000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60909000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25443000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26084000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15226000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	16248000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	169570000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	167724000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10919000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11260000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23460000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24918000	usd
CY2023Q2	us-gaap	Assets Assets	664627000	usd
CY2022Q4	us-gaap	Assets Assets	835443000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	74014000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	184016000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100902000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98959000	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	12084000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	13208000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	27000000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	214000000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	296183000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31581000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	33247000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	526000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	931000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23081000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29366000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	55188000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	63544000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	269188000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	359727000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27594000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27594000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27423000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27423000	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	276000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	274000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	263837000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	257498000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	118303000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	199415000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	13023000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18529000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	395439000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	475716000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	664627000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	835443000	usd
CY2023Q2	us-gaap	Revenues Revenues	160292000	usd
CY2022Q2	us-gaap	Revenues Revenues	291969000	usd
CY2023Q2	irbt	Costofproductrevenue Costofproductrevenue	123459000	usd
CY2022Q2	irbt	Costofproductrevenue Costofproductrevenue	183633000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	282000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	821000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	123741000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	184454000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	36551000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	107515000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41934000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42529000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	44765000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	61065000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30971000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26698000	usd
CY2023Q2	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	178000	usd
CY2022Q2	irbt	Amortizationof Intangible Assets Nonproduction AmortizationofIntangibleAssetsNonproduction	510000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	117848000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	130802000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-81297000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-23287000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1077000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16746000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-82374000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40033000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1262000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9627000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-81112000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-30406000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.95
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.95
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27467000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27051000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27467000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27051000	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-81112000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-30406000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	1720000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-4015000	usd
CY2023Q2	irbt	Other Comprehensive Income Loss Cash Flow Hedge Unrealized Gain Loss Net Of Tax OtherComprehensiveIncomeLossCashFlowHedgeUnrealizedGainLossNetOfTax	-1823000	usd
CY2022Q2	irbt	Other Comprehensive Income Loss Cash Flow Hedge Unrealized Gain Loss Net Of Tax OtherComprehensiveIncomeLossCashFlowHedgeUnrealizedGainLossNetOfTax	7653000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	5403000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1234000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-86618000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28002000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	475716000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7932000	usd
CY2023Q2	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	1600000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5506000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-81112000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	395439000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	716723000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	797000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7208000	usd
CY2022Q2	irbt	Stock Withheld To Cover Tax Withholding Requirements Upon Vesting To Restricted Stock Units Amount StockWithheldToCoverTaxWithholdingRequirementsUponVestingToRestrictedStockUnitsAmount	1524000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2404000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2404000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-30406000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	695202000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-81112000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-30406000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7542000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11241000	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-16835000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7932000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7208000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-647000	usd
CY2022Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	15571000	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3562000	usd
CY2022Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1539000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-37147000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-54299000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-52947000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1688000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-53000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	26734000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-109930000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-77006000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-6171000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-42032000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-94507000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-102315000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1456000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3113000	usd
CY2023Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	73000	usd
CY2022Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	500000	usd
CY2023Q2	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	0	usd
CY2022Q2	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-16213000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1529000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12600000	usd
CY2023Q2	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	9000	usd
CY2022Q2	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	797000	usd
CY2023Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1600000	usd
CY2022Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1524000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	27000000	usd
CY2022Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25409000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-727000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	593000	usd
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1023000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-70034000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-89419000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117949000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	201457000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47915000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112038000	usd
CY2023Q2	us-gaap	Nature Of Operations NatureOfOperations	Nature of the Business<div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iRobot Corporation ("iRobot" or the "Company") designs, builds and sells robots and home innovations that make life better. The Company's portfolio of home robots and smart home devices features proprietary technologies for the connected home and advanced concepts in cleaning, mapping and navigation, human-robot interaction and physical solutions. iRobot's durable and high-performing robots are designed using the close integration of software, electronics and hardware. The Company’s revenue is primarily generated from product sales through a variety of distribution channels, including chain stores and other national retailers, through the Company's own website and app, dedicated e-commerce websites, the online arms of traditional retailers and through value-added distributors and resellers worldwide. </span></div><div style="margin-top:5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger Agreement</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2022, the Company entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among the Company, Amazon.com, Inc., a Delaware corporation ("Parent" or "Amazon") and Martin Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each share of common stock of the Company, par value $0.01 per share ("Common Stock"), outstanding immediately prior to the effective time of the Merger (the "Effective Time") (subject to certain exceptions, including shares of Common Stock owned by the Company, Merger Sub, Parent or any of their respective direct or indirect wholly owned subsidiaries and shares of Common Stock owned by stockholders of the Company who have validly demanded and not withdrawn appraisal rights in accordance with Section 262 of the General Corporation Law of the State of Delaware) will, at the Effective Time, automatically be cancelled and converted into the right to receive $61.00 in cash, without interest and subject to applicable withholding taxes. If the Merger is consummated, the Company’s Common Stock will be delisted from the Nasdaq Stock Market LLC and deregistered under the Securities Exchange Act of 1934.</span></div>
CY2023Q2	us-gaap	Inventory Net InventoryNet	229700000	usd
CY2023Q2	irbt	Days In Inventory DaysInInventory	P169D
CY2023Q2	irbt	Increase Decrease In Inventory Net IncreaseDecreaseInInventoryNet	-55600000	usd
CY2023Q2	us-gaap	Fiscal Period FiscalPeriod	The Company operates and reports using a 52-53 week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company’s fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter.
CY2023Q2	irbt	Revenue Increase Decrease RevenueIncreaseDecrease	-0.45
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-81300000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-94500000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117900000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47900000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	27000000	usd
CY2022Q4	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	100	employee
CY2022Q4	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.08
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	85	employee
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.07
CY2023Q2	dei	Entity Number Of Employees EntityNumberOfEmployees	1156	employee
	irbt	Increase Decrease In Employees Employed By The Entity IncreaseDecreaseInEmployeesEmployedByTheEntity	-216	employee
CY2023Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:5pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenue and expenses. These estimates and judgments, include but are not limited to, revenue recognition, including performance obligations, standalone selling price, variable consideration and other obligations such as sales incentives and product returns; allowance for credit losses; impairment of goodwill and long-lived assets; valuation of non-marketable equity investments; product warranties; inventory excess and obsolescence; loss contingencies; and accounting for income taxes and related valuation allowances. The Company bases its estimates and assumptions on historical experience, market participant fair value considerations, projected future cash flows, current economic conditions, and various other factors that the Company believes are reasonable under the circumstances. Actual results and outcomes may differ from the Company’s estimates and assumptions.</span></div>
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2700000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4700000	usd
CY2022Q1	us-gaap	Receivable For Recovery Of Import Duties Net ReceivableForRecoveryOfImportDutiesNet	32000000	usd
CY2023Q2	irbt	Cash From Recovery Of Import Duties Net CashFromRecoveryOfImportDutiesNet	28000000	usd
CY2023Q2	us-gaap	Receivable For Recovery Of Import Duties Net ReceivableForRecoveryOfImportDutiesNet	4000000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	15100000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	15100000	usd
CY2022Q3	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	100	employee
CY2022Q4	us-gaap	Restructuring Charges RestructuringCharges	5200000	usd
CY2022Q4	irbt	Restructuring Noncash Impairment Loss RestructuringNoncashImpairmentLoss	3400000	usd
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	85	employee
CY2023Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.07
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	3700000	usd
CY2023Q2	irbt	Restructuring Liabilities RestructuringLiabilities	1900000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	23200000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-81112000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-30406000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27467000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27467000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27051000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27051000	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.95
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.95
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	21400000	usd
CY2023Q2	irbt	Refundliabilityproductreturns Refundliabilityproductreturns	21700000	usd
CY2023Q2	irbt	Refundliabilityothercreditsandincentives Refundliabilityothercreditsandincentives	56800000	usd
CY2022Q4	irbt	Refundliabilityproductreturns Refundliabilityproductreturns	49200000	usd
CY2022Q4	irbt	Refundliabilityothercreditsandincentives Refundliabilityothercreditsandincentives	106500000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	160292000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	291969000	usd
CY2023Q2	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	24891000	usd
CY2022Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	60268000	usd
CY2023Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5284000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	6569000	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	21741000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24140000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4200000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4700000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0403
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M10D
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1715000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	851000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	825000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	918000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	2540000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	1769000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	42445000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	2008000	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	2039000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5279000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6618000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5794000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5816000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5890000	usd
CY2023Q2	irbt	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	13048000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5356000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	37089000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5508000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31581000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	167724000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11260000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	460000	usd
CY2023Q2	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1846000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	119000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	169570000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10919000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	24618000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	27379000	usd
CY2023Q2	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	16095000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	17620000	usd
CY2023Q2	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	14909000	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	1312000	usd
CY2023Q2	irbt	Accrued Merger And Related Liabilities Current AccruedMergerAndRelatedLiabilitiesCurrent	11791000	usd
CY2022Q4	irbt	Accrued Merger And Related Liabilities Current AccruedMergerAndRelatedLiabilitiesCurrent	10895000	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7202000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7310000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5508000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5415000	usd
CY2023Q2	irbt	Accrued Manufacturing And Logistics Costs AccruedManufacturingAndLogisticsCosts	4516000	usd
CY2022Q4	irbt	Accrued Manufacturing And Logistics Costs AccruedManufacturingAndLogisticsCosts	970000	usd
CY2023Q2	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	4190000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	4538000	usd
CY2023Q2	irbt	Accrued Sales Tax AccruedSalesTax	2898000	usd
CY2022Q4	irbt	Accrued Sales Tax AccruedSalesTax	7683000	usd
CY2023Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	350000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	5070000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8825000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10767000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100902000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98959000	usd
CY2023Q2	us-gaap	Revenues Revenues	160292000	usd
CY2022Q2	us-gaap	Revenues Revenues	291969000	usd
CY2023Q2	us-gaap	Contractual Obligation ContractualObligation	228700000	usd
CY2023Q2	irbt	Contractual Obligation Inventory ContractualObligationInventory	82500000	usd
CY2023Q2	irbt	Contractual Obligation Noncancellable Without Penalty ContractualObligationNoncancellableWithoutPenalty	43100000	usd
CY2023Q2	irbt	Payments For Contractual Obligations PaymentsForContractualObligations	3900000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	27379000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	32019000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	3477000	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	6036000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	6238000	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	7816000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	24618000	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	30239000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1300000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9600000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.015
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.240
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	57500000	usd
CY2023Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment

Files In Submission

Name	View Source	Status
irbt-20230401_pre.xml	Edgar Link	unprocessable
irbt-20230401_cal.xml	Edgar Link	unprocessable
0001159167-23-000036-index-headers.html	Edgar Link	pending
0001159167-23-000036-index.html	Edgar Link	pending
0001159167-23-000036.txt	Edgar Link	pending
0001159167-23-000036-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
irbt-20230401.htm	Edgar Link	pending
irbt-20230401.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
irbt-20230401_def.xml	Edgar Link	unprocessable
irbt-20230401_lab.xml	Edgar Link	unprocessable
irbt-20230401_htm.xml	Edgar Link	completed
irbtexhibit3114123.htm	Edgar Link	pending
irbtexhibit3124123.htm	Edgar Link	pending
irbtexhibit3214123.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRBT
IROBOT CORP Stock $irbt

2023 Q2 Form 10-Q Financial Statement

#000115916723000036 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT IROBOT CORP Stock $irbt

2023 Q2 Form 10-Q Financial Statement

#000115916723000036 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRBT
IROBOT CORP Stock $irbt